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the effect of the current unstable political and economic
situation on the subjects, which is undoubtedly an additional
stress factor. As the subjects in the research were white,
predominantly middle-class women, the findings cannot be
generalised to other ethnic or socio-economic groups. The
study highlights the need for further research in this area, and
suggests some of the factors that should be considered.
We would like to thank Or D·. D. Largier and the anonymous
referee for their useful comments on a previous draft of this
paper.
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Objective. To confirm the association of antiphospholipid
antibodies with early onset of severe pre-eclampsia before
30 weeks' gestation.
StUdy design. Thirty-four patients with diastolic blood
pressure levels;;. 110 mmHg and at least 2+ proteinuria
before the 30th week of pregnancy were randomly chosen
for inclusion in the study. Blood samples were taken for
assessment of anticardiolipin antibodies (ACAs), lupus
anticoagulant, syphilitic serology and antinuclear
antibodies. Fifteen normal antenatal patients matched for
age, parity and gestational age acted as control subjects.
Results. Four of the 34 women (11,7%) in the study
group had elevated levels of both ACAs and lupus
anticoagulant, compared with none in the control group.
This was not found to be statistically different.
Conclusion. Given the low incidence of positive ACAs in
early-onset severe pre-eclampsia it is unlikely that they are
implicated in its pathogenesis. It is possible that they
represent a small subset of patients with alternative or
combined pathology.
S Afr Med J 1995; 85: 105-107.
Antibodies, in particular those directed at negatively charged
phospholipids such as cardiolipin and phosphatidylinositol,
have been implicated in placental dysfunction. Several
mechanisms have been proposed to explain the association
of high titres of antiphospholipid antibodies (APAs) and
pregnancy loss. One hypothesis is that these maternal
antibodies decrease prostacyclin production by placental
tissue, with resultant thrombosis.'2 Other possibilities are
that antibodies can bind platelet and endothelial cell
membranes, affect cell function and promote thrombosis.
Because there are similarities in placental pathology in
patients with APAs and those with pre-eclampsia, viz.
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Discussion
Details of the 4 patients with significant APAs are shown
in Table 11. Two of the patients with APAs delivered
premature neonates at 32 weeks' gestation. The othe~:2
patients had spontaneous intra-uterine deaths. None·of the
patients in the control group suffered a perinatal loss, ~hile
the perinatal loss in the 30 patients in whom APAs were not
detected was 70%. Maternal signs of pre-eclampsia'
regressed within a week of delivery.
Conflicting reports~8 on the association of APAs and pre-
eclampsia have been published. Rajah et a/. 8 and Scotl'
found no significant difference in ACA levels between study
and control groups. Rajah et a/. 8 studied patients in late
pregnancy while Branch et al. 6 reported that one-third of
women with severe pre-eclampsia occurring before 34
weeks' gestation had high titres of ACA. Our study shows
that although 4 of 34 women with severe pre-eclampsia, a
clinically important proportion (11,7%), had elevated APAs
before 30 weeks, statistical significance was not achieved.
Reports on studies involving large numbers of patients
however also found no differences in APA levels between
patients with severe early-onset pre-eclampsia and
controls."lO Further, Kilpatrick et a/. '°state that even Branch
et a/. 6 found ACAs in only 16% of their patients.
In the present study, both ACA and LAC levels were
assayed, and all 4 patients had significantly raised APA
levels with elevated titres on both antibody tests. The ACA
test is generally accepted as the most sensitive.' In addition
tests for nuclear antibodies and smooth-muscle antibodies,
as well as syphilitic serology, were negative in all patients.
Nuclear antibodies were sought by testing patients' sera on
Table I. Clinical data (means and ranges)
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Diastolic (mmHg) 128,2 (110 - 160)
No. of ACA positive 4
No. of LAC positive 4






Results are reported as means and the ranges are given.
The chi-square test was used to compare differences
between groups and, where necessary, Fisher's exact test
was used.
Four of the 34 women (11,7%) with early onset of severe
pre-eclampsia (study group) had elevated levels of both
ACAs and LAC compared with none in the control group.
This, however, was not found to be statistically different
(Table I). The mean values of AeA and LAC in the 4 patients
were 4,7 (1,5 - 12; SD 5,3) and 1,6 (1,4 - 2,1; SD 0,35)
respectively.
Methods
Following institutional ethical approval and informed
consent, 34 patients with severe pre-eclampsia prior to
the 30th week of gestation were admitted to the study.
All had singleton pregnancies, diastolic blood pressures of
110 mmHg or higher and proteinuria of ++ or more (detected
semiquantitatively by Testape (Ames». Patients with
essential hypertension or on corticosteroid therapy were
excluded, as were patients who were seropositive for
syphilis and antinuclear factor. ACAs were analysed by a
modified enzyme-linked immunosorbent assay (ELlSA)
technique described by Harris.5 No attempt was made to
differentiate between IgG and IgM antibodies; only IgG
antibodies were sought. Results were recorded as an ACA
index and a value of > 1,3 was regarded as significant.
The index is calculated as the mean optical density of the
sample divided by 1,5 x optical density of a standard
negative. Lupus anticoagulant antibodies (LACs) were
detected by the activated partial thromboplastin time (Pn),
the 50:50 PTT and the Exner test. LACs were reported as a
ratio of the normal and a value of > 1,35 was regarded as
abnormal. Fifteen normal antenatal patients, matched for
age (± 5 years), parity and gestational age (± 2 weeks),
acted as control subjects.
microthrombi and infarcts, some authors have suggested an
association between pre-eclampsia and anticardiolipin
antibodies (ACAs).''' These reports, however, included many
patients on large doses of corticosteroids, a potentIal cause
of hypertension. The purpose of our study was to confirm
the association of APAs with severe early-onset pre-
eclampsia.
Table 11. Details of APA-positive patients
Gestational Blood pressure AeA LAC Neonatal Maternal
Patient age (wks) Parity (mmHg) index ratio outcome complications
6 21 3 1901140 2,2 1,49 IUD (450 g) Nil
14 18 1 1801120 2,5 1,35 Preterm delivery (1 200 g) Renal damage
24 28 0 170/110 1,5 1,4 IUD (1 1QO g) HELLP syndrome
33 26 3 160/120 12,6 2,1 Preterm Severe uncontrollable
hypertension
ACA anticardiolipin antibody; LAC lUpus anticoagulant; IUD - intra·uterine death; HELLP - haemolysis. elevated liver enzyme levels, low platelet levels
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a composite block of mouse liver, kidney and stomach
substrate. Anti-smooth-muscle antibodies were, however,
not sought. The ELlSA for AeA was standardised in our
laboratory according to the Rayne Institute (London, UK)
standard serum samples.
The actual significance of increased titres of APA in
patients with pre-eclampsia is not known. Although the
perinatal outcome in the 4 patients with ACA was poor, the
perinatal ol!tcome in patients who had no antibodies was
similar. The pathogenic role of ACA is undefined as low titres
in normal pregnancies elicited either as a physiological
response to normal pregnancy or as a general response to
tissue injury have also been reported."'" Given the low
incidence of positive ACAs in severe pre-eclampsia it is
unlikely that they are implicated in the pathogenesis of pre-
eclampsia. It is possible that they represent a small subset
of patients with alternative or combined pathology. The
clinical importance of detection is that these patients may
have a poor pregnancy outcome. Further study is indicated.
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Three case studies and a review of the
literature
A. Bassa, D. K. Desai, J. Moodley
Takayasu's disease is commonest in women of
childbearing age. Obstetricians are therefore faced with
the dilemma of optimal management in pregnancy. This
report of 3 cases suggests that Takayasu's disease is
associated with a good maternal and fetal outcome. The
basic disease appears to be unaffected by pregnancy.
S Afr Med J 1995; 85: 107-112.
Takayasu's disease is an idiopathic chronic granulomatous
large-vessel arteriopathy, affecting predominantly the aorta
and its main branches. The condition, although rare, is more
common in women in whom it presents at childbearing age.
Obstetricians are thus faced with the dilemma of optimal
management in pregnancy. We report 3 cases of Takayasu's
disease managed recently at King Edward VIII Hospital and
review the literature on this rare condition.
Case reports
Case 1
A 21-year-old primigravida was referred from a community
clinic with a diagnosis of 'aproteinuric hypertension' in the
30th week of pregnancy. She was asymptomatic. On
examination, all pulses in both upper limbs were absent.
The carotid pulses were weakly palpable and all pulses in
both lower limbs were present. The popliteal blood pressure
was 190/100 mmHg and precordial examination revealed no
evidence of established hypertension. There were no
abdominal bruits. Funduscopy was normal and urine
examination did not reveal proteinuria. A clinical diagnosis of
group 11 Takayasu's disease was made.
Investigations revealed a positive Rhesus factor and an
erythrocyte sedimentation rate (ESR) of 18 mm/h. The chest
radiograph, electrocardiography (ECG), echocardiogram and
an ultrasonograph of the kidneys were normal. Doppler
studies of the upper limb and carotid vessels revealed good
collateral circulation. Serological tests for syphilis and
rheumatoid factor were negative. The Mantoux test was
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